Plasma IP-10 and MCP-3 levels are highly associated with disease severity and predict the progression of COVID-19

BACKGROUND: The outbreak of coronavirus disease 2019 (COVID-19) caused by the severe acute respiratory syndrome coronavirus 2 was first reported in Wuhan, December 2019, and continuously poses a serious threat to public health, highlighting the urgent need of identifying biomarkers for disease sever...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:J Allergy Clin Immunol
Auteurs principaux: Yang, Yang, Shen, Chenguang, Li, Jinxiu, Yuan, Jing, Wei, Jinli, Huang, Fengmin, Wang, Fuxiang, Li, Guobao, Li, Yanjie, Xing, Li, Peng, Ling, Yang, Minghui, Cao, Mengli, Zheng, Haixia, Wu, Weibo, Zou, Rongrong, Li, Delin, Xu, Zhixiang, Wang, Haiyan, Zhang, Mingxia, Zhang, Zheng, Gao, George F., Jiang, Chengyu, Liu, Lei, Liu, Yingxia
Format: Artigo
Langue:Inglês
Publié: American Academy of Allergy, Asthma & Immunology 2020
Sujets:
Covid-19
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC7189843/
https://ncbi.nlm.nih.gov/pubmed/32360286
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jaci.2020.04.027
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires